CARDIAC SCREENING AND CARDIAC ARREST ON THE PITCH
– Written by Mats Borjesson, Sweden
The whole football world shockingly watched the event of Christian Eriksens collapse during the Denmark-Finland game at the Euros, in June 2021. After successful resuscitation he survived the event of sudden cardiac arrest (SCA). While everybody was relieved at this turn of events, the question was asked: can this be prevented?
In the last 20 years a great development in cardiac health of athletes has taken place. Way back, the importance of pre-screening of athletes included the 3H´s (heart, hernia and how do you feel?). However, in many countries in the beginning of the 1980´s, you could play at highest level without ever being evaluated for heart conditions. This may be due to several reasons, but the lack of specificity of ECG-interpretation of athletes was one obstacle. Then in the 2000´s Sports Cardiology was established as part of the European Society of Cardiology (ESC) and American Heart Association, worldwide leading cardiology societies.
The first recommendations from the ESC for cardiac screening for competitive athletes was published in 20051. Since then, international recommendations for the interpretation of the ECG in athletes has been produced in 20172. In 2021, for the first time Guidelines of Sports Cardiology from the ESC, on sports and exercise in athletes with underlying cardiovascular disease, was published3. Importantly, as a result of varying degree of readiness for adverse cardiac events at arenas, recommendations for arena safety, including a medical action plan (MAP), was produced in 2011 by the ESC4, and subsequently by FIFA5. This development has been possible as a result of the increasing knowledge in the field of Sports Cardiology. Now, Sports Cardiology is a recognized sub-speciality of Cardiology in Europe6, hopefully expanding towards a common worldwide curriculum.
The causes of sudden cardiac death in young athletes (<35 years) are mainly, but not exclusively, inherited cardiac abnormalities such as hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (formerly right ventricular cardiomyopathy), coronary artery anomalies, long QT-syndrome and various ion-channel diseases (Brugada syndrome, PCVT…)7. A number of cases cannot be attributed to any specific underlying disease. However, most of these cases are expected to show underlying disease, as genetic testing is developing8. Overall, 1/250 athletes are expected to show an underlying cardiac abnormality, being associated with increased risk of SCA during sports. Many of these entities show abnormalities on the resting 12-lead ECG, and individuals suffering from SCA often have previous symptoms, such as exercise-related yncope, dyspnoea, palpitations or chest pain and/or show a familiar history of SCA and/or inherited cardiac disease9.
SCREENING – THE FIRST LINE OF DEFENCE
Because of the possible preventability of these events, recommendations on cardiac screening were produced, both in Europe and in the US1,10. They include:
1. Careful evaluation of family history and cardiac symptoms.
2. Physical evaluation.
3. 12-lead resting ECG1.
The sensitivity of the screening recommendations has been shown to be high, and thus, the potential for detecting a majority of individuals with underlying disease. For example, a recent Swedish study, including all cases of sudden cardiac death (SCD) due to HCM in young athletes, showed that 88% of cases, showed any abnormality (family history, symptoms or ECG-changes) prior to death11. Indeed, relying on family history, symptoms and physical evaluation has shown considerably lower sensitivity, with the ECG adding significantly to the sensitivity of screening12.
The main issue of cardiac screening including ECG, concerns the specificity. Indeed, cardiac screening without the ECG has very low specificity, due to the often diffuse, potentially cardiac, symptoms listed above13. These symptoms are very common in athletes and therefore needs to be penetrated by an experienced (team)physician. Often, this evaluation will necessitate a resting-ECG.
However, also the ECG has limitations. Physiologic adaptations, secondary to long-standing, sporting activities, may also affect the heart. The degree of adaptation, will depend on several factors, including the type of training, intensity, level of sporting activity, age and duration of the training exposure, ethnicity, and sex14. These changes, typically referred to as “athlete´s heart” will involve enlargement of the cardiac ventricles and walls, of varying degrees. If significant, these changes will be recognized by a resting-ECG. However, various underlying cardiac abnormalities also show ECG-changes, which may be similar to the ones resulting from physiologic adaptation2. Historically, manual percussion of cardiac size and later, x-ray, were the first diagnostic tools, indicating an “enlarged heart”. The ECG has refined this categorization and repeated updates of recommendations on how to interpret the ECG in athletes, differentiating physiologic adaptations from underlying pathology, has refined the criteria for abnormality. Today, ECG shows high sensitivity (as before), but also a markedly improved specificity, with a few % “false-positives” at best. This development has greatly aided the implementation of screening recommendations in clinical practice, including FIFAs pre-competition medical assessment (PCMA)15. In case of uncertainty, symptoms and/or ECG-abnormalities suspected to be non-physiological, additional evaluation by echocardiography and/or exercise-testing is advocated2,16. The advantages of the ECG are the widespread availability, low cost and high sensitivity. However, there is still a need to increase the knowledge of cardiac screening in general and specifically of ECG-interpretation, in sports medicine physicians and team doctors, outside the field of cardiology.
Cardiac screening is not 100%. Although screening has the potential to discover the majority of individuals with an underlying significant cardiac abnormality, a part of athletes will go unnoticed, having subclinical disease. For the young, this would most probably be ion-channel disease. As proposed, widening the screening to make echocardiography mandatory, would have cost implications. However, major sporting organizations, such as FIFA and UEFA, have decided to make echocardiography mandatory, as part of the pre-competition medical assessment (PCMA)15 at this level of competition, where it is both logistically and economically feasible.
CARDIAC ABNORMALITIES NOT DETECTED BY SCREENING
Not all cardiac entities are detectable by screening. In the case of infectious myocarditis, mainly caused by cardiotropic viruses, prevention is the key. No player should be recommended to play or train, during an ongoing infection. This has been particularly highlighted during the covid-pandemic. While the initial worry about an abundance of cardiac complications to covid17, has been partly downplayed, also covid could cause myocarditis, and possible non-infectious cases of myocarditis post-vaccination, has been described18.
Another special cardiac event, not possible to prevent by cardiac screening, is commotio cordis. This entity is a major cause of SCA in the (very) young athletes, in the US often associated to baseball, but has also been described in ice-hockey and football19. The unlucky hit of a non-air-filled object (puck, baseball) in the chest area, over the heart, at a certain time frame in the heart cycle, could give rise to malignant arrythmias, including ventricular tachycardia and even death. Commotio cordis is hard to prevent, although protective gear and softer balls have been tried. The major line of defence is appropriate cardiac resuscitation in case of SCA.
ARENA SAFETY- SECOND LINE OF DEFENCE
Alas, readiness at sporting events, in case of SCA is essential. “Arena safety”, thus constitutes the second line of defence, to save an individual from death, in case of SCA.
The major factor associated with survival from SCA, is time to cardiopulmonary resuscitation (CPR) and time to defibrillation20. Thus, one major factor is the early recognition of an arrest. While SCA is an uncommon event, team doctors should be aware of the signs of an arrest, so minimal “doctor´s delay” occurs. Always, when a player collapses without any visible trauma, and falls to the ground, SCA should be suspected. The immediate actions, include determining ABC (airway, breathing, circulation) as soon as the player is reached. If no signs of consciousness, pulse and breathing, SCA is established and CPR must be initiated, ideally within 1 minute from the event occurring4,20. While CPR commences, pitch medical staff, will be summoned, for application of an automated external defibrillator (AED), in case of arrest, ideally within 3-5 minutes4.
The 30-day survival of exercise-related out of hospital cardiac arrests, are significantly higher compared to non-exercise related out of hospital arrests21. This is due to a combination of a higher degree of arrests being witnessed; by earlier CPR and earlier defibrillation. While women show a much lower incidence of SCA during sports, the survival from arrest is lower21,22. This merits consideration, and future studies, as the suspicion of women having a cardiac arrest may be lower. This is indicated by the findings of a lower rate of and slower initiation of CPR, in women22. Sex-related differences in underlying cardiac abnormalities may also be of importance, as could differences in sporting activities between genders worldwide. The survival of the youngest in case of SCA has been debated. In the Swedish study, however, the survival was not lower for the youngest athletes (<25 years) compared to the older and the 25-35 year olds22.
The significance of an AED was established outside sports, in surroundings such as casinos and airports, showing a higher survival when AEDs were present. This development has led to the vast increase in AEDs in public places (also taxis and shopping malls etc) as well as in sports stadiums. However, it is important that just placing an AED in a stadium or training ground is not enough. The establishment of a medical action plan (MAP) is essential4. The MAP should include information on the responsible doctor, the personnel, communication methods and equipment of the stadium, but also on how training of the medical staff is ascertained. The MAP should also include information on how to connect to the regular emergency care in a particular city, from the stadium and onwards. Any weak link in this “chain” may result in a lower survival, in case of SCA.
IS IT WORKING?
The effectiveness of a cardiac screening programme is difficult to evaluate. The occurrence of SCA is low and any intervention studies, needs to be carefully constructed. Do we have any evidence? No randomized controlled study of screening vs no screening has been performed, and the likeliness of such as study taking place is low. However, we have some studies indicating the effect of screening and arena safety. The most known study, is the one on cardiac screening in the Veneto-region of Italy, showing a marked decline in the incidence of SCD associated to cardiac screening being introduced23. The incidence of SCD in the athletic population, was actually lower than the incidence of SCA in the normal population! However, the rates of SCD at the beginning of the study was comparatively high, contributing to the results. For any study to be useful, we must have a non-selected population, ideally comprising all individuals of a large region or even a country. The Swedish national registry of SCD in ALL young individuals <35 years of age, offers opportunities to study both aetiology and incidence of SCA in a totally unselected and comprehensive population (the whole population). Interestingly, we could show that the number of athletes suffering from SCD in the years 2000-10 was half that, compared to the years 1990-9924. The study cannot determine which factor was the most important: the introduction of screening, education and/or the increased availability of AEDs in public places and sports arenas. All these things have developed during the years since the mid-1990´s and could be contributing to the results at a varying degree. However, the study perfectly illustrates the potential to decrease a nation-wide incidence rate of SCA, by applying the “lines of defence”, discussed in this paper.
EDUCATION – THIRD LINE OF DEFENCE?
The need for (further) education at different levels of medical staff and on different topics could be identified, including on:
· How to perform cardiac screening, for the team physician. This also includes interpretation of ECG´s, recognizing the major abnormalities or “red flags”, indicating the need for further evaluation by a cardiologist.
· The transfer of theoretical knowledge of handling of an SCA to practical training. Clinical training sessions, or courses are needed for the relevant medical personnel, especially those present at sporting events with a significant number of participants and/or spectators.
· How to produce a medical action plan (MAP) for physicians engaged in event planning.
· Increased basic knowledge in the field of Sports Cardiology, including aetiology of SCA at various ages etc, should be part of any future sports medicine/football medicine education/curriculum.
The field of Sports Cardiology has experienced a very exciting development in the last decades, now being recognized as a vital part of any football doctors´ broad knowledge. The combination of cardiac screening and arena safety measures, alongside public and professional knowledge and awareness, has the potential to reduce the incidence of SCA and most importantly SCD in sports. While much research remains to be conducted, the implementation of the present knowledge in screening and arena safety will help the athletes and medical staff in this endeavour.
Mats Borjesson M.D.
Center for Health and Performance, Dept of Molecular and Clinical Medicine,
Sahlgrenska Academy, University of Gothenburg
Sahlgrenska University Hospital
Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G; Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J. 2005 Mar;26(5):516-24.
Sharma S, Drezner JA, Baggish A, Papadakis M, Wilson MG, Prutkin JM, LaGerche A, Ackerman MJ, Borjesson M, Salerno JC, Asif IM, Owens DS, Chung EH, Emery MS, Froelicjer VF, Heidbuchel H, Adamuz C, Asplund CA, Cohen G, Harmon KG, Marek JC, Molossi S, Niebauer J, Pelto HF, Perez MV, Riding NR, Saarel T, Schmied CM, Shipon DM, Stein R, Vetter VL, Pelliccia A, Corrado D. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 2018;39:1466-80.
Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J 2021; 42: 17-96. PMID: 32860412.
Borjesson M, Dugmore D, Mellwig K-P, van Buuren F, Serratosa L, Solberg E, Pelliccia A. Time for action regarding cardiovascular emergency care at sports arenas: lessons from the Arena study. Eur Heart J 2010; 31:1438-41.
Dvorak J, Kramer EB, Mandelbaum B, et al. Mass-gathering football medciine. In: Dvorak J, Kramer EB (eds), Football Emergency Medical Manual (2nd Ed), Zurich, FIFA;2015;72-109.
Heidbuchel H, Papadakis M, Panhuyzen-Goedkoop N, Carré F, Dugmore D, Mellwig KP, Rasmusen HK, Solberg EE, Borjesson M, Corrado D, Pelliccia A, Sharma S. Position paper: Proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol. 2013;20:889-903.
Schmied C, Börjesson M. Sudden cardiac death in athletes. J Int Med 2014; 275:93-103.
Mazzanti A, Priori SG. Molecular autopsy for sudden unexplained death? Time to discuss pros and cons. J Cardiovasc Electrophysiol 2012;23:1099-1102.
Schiavon M, Zorzi A, Corrado D. History and physical examination. In: Pelliccia A, Heidbuchel H, Corrado C, Borjesson M, Sharma S (eds), The ESC Textbook of Sports Cardiology, Oxford Univ Press, Oxford, UK. 2019; 51-56.
Maron BJ, Levine BD, Washington RL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities. Task Force 2. Circulation 2015;132:e267-72.
Borjesson EN, Svennblad B, Wisten A, Borjesson M, Stattin E-L. Symptoms and ECG-changes precludes sudden cardiac death in hypertrophic cardiomyopathy- a nationwide study among the young in Sweden. Abstract presented at Europrevent, April 2021.
Baggish AL, Hutter AM Jr, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 2010; 152:269-75.
Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis. J Electrocardiol 2015;48:329-38.
Sheikh N. Impact of sporting discipline, gender, ethnicity, and genetics on the athlete´s heart. In: In: Pelliccia A, Heidbuchel H, Corrado C, Borjesson M, Sharma S (eds), The ESC Textbook of Sports Cardiology, Oxford Univ Press, Oxford, UK. 2019; 20-32.
Dvorak J, Grimm K, Schmied C, Junge A. Development and implementation of a standardized precompetition medical assessment of international elite football players-2006 FIFA World Cup Germany. Clin J Sports Med 2009;19:316-21.
Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carrè F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G; Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005 Jul;26(14):1422-45.
Bhatia RT, Marwaha S, Malhotra A, Iqbal Z, Borjesson M, Niebauer J, Pelliccia A, Schmied C, Serratosa L, Papadakis M, Sharma S. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts. Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020 Aug;27(12):1242-1251. PMID: 32475157.
Pepe S, Gregory AT, Denniss AR. Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination (editorial). Heart, Lung and Circ 2021. https//doi.org/10.1016/j.hlc.2021.07.011
Solberg E, Embrå BI, Börjesson M, Herlitz J, Corrado D. Commotio cordis-underrecognised in Europe?- a case report. Eur J Cardiovasc Prev Rehabil, 2011;18: 378-83.
Perkins GD, Handley AJ, Koster RW, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 2, Adult basic life support and automated external defibrillation. Resuscitation 2015;95:81-99.
Frisk Torell M, Strömsöe A, Zagerholm E, Herlitz J, Claesson A, Svensson L, Börjesson M. Higher survival rates in exercise-related out-of-hospital cardiac arrests, compared to non-exercise-related - a study from the Swedish Register of Cardiopulmonary Resuscitation. Eur J Prev Cardiol 2017;24:1673-9.
Frisk-Torell M, Stromsoe A, Herlitz J, Claesson A, Rawshani A, Borjesson M. Better outcome of exercise-related out-of-hospital cardiac arrest in men and in the young- findings from the Swedish registry of pulmonary resuscitation. Submitted.
Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601.
Wisten A, Börjesson M, Krantz P, Stattin E-L. Exercise related sudden cardiac death (SCD) in the young - pre-mortal characterization of a Swedish nationwide cohort, showing a decline in SCD among athletes resuscitation 2019, 144:99-105.
Header image by @cfcunofficial (Cropped)
Targeted Topic - Hot Topics in Football Medicine
view all articles in this issue